0001179110-12-016092.txt : 20121115 0001179110-12-016092.hdr.sgml : 20121115 20121115150332 ACCESSION NUMBER: 0001179110-12-016092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121113 FILED AS OF DATE: 20121115 DATE AS OF CHANGE: 20121115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SKALETSKY MARK B CENTRAL INDEX KEY: 0001073379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 121208420 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml FORM 4 - X0306 4 2012-11-13 0 0000855654 IMMUNOGEN INC IMGN 0001073379 SKALETSKY MARK B 22 PURITAN ROAD NEWTON MA 02461 1 0 0 0 Deferred Share Unit 0 2012-11-13 4 A 0 2626 0 A 2013-02-01 Common Stock 2626 2626 D Stock option (right to buy) 11.42 2012-11-13 4 A 0 4645 11.42 A 2013-02-01 2022-11-13 Common Stock 4645 4645 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest ratably over a one year period in quarterly increments beginning on February 1, 2013, contingent upon the individual remaining a director as of each vesting date. Exercisable as to 1,162 shares commencing on February 1, 2013, 1,161 shares commencing on May 1, 2013, 1,161 shares commencing on August 1, 2013 and 1,161 shares commencing on November 1, 2013, contingent upon the individual remaining a director as of each vesting date. /s/ Craig Barrows, attorney in fact 2012-11-15